Inactive Instrument

Tabula Rasa HealthCare, Inc.

Equities

TRHC

US8733791011

Advanced Medical Equipment & Technology

Tabula Rasa Healthcare, Inc. Provides Financial Guidance for the Full Year Ended December 31, 2020

January 12, 2021 at 06:30 pm IST

Tabula Rasa HealthCare, Inc. provided financial guidance for the full year ended December 31, 2020. Full year 2020 revenue is expected to be at the top end of guidance range of $294 million to $296 million.

Latest news about Tabula Rasa HealthCare, Inc.

Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from S&P TMI Index	07/11	CI
Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from S&P Global BMI Index	07/11	CI
Tabula Rasa Healthcare, Inc. Announces Board Changes	06/11	CI
Tabula Rasa HealthCare, Inc.(NasdaqGM:TRHC) dropped from NASDAQ Composite Index	03/11	CI
Exact Care Pharmacy, LLC completed the acquisition of Tabula Rasa HealthCare, Inc. from Indaba Capital Fund, L.P, managed by Indaba Capital Management, L.P. and others.	03/11	CI
North American Morning Briefing : Sentiment Hit by -2-	08/23/08	DJ
Sector Update: Health Care Stocks Advancing in Late Afternoon Trading	08/23/08	MT
Sector Update: Health Care Stocks Rising in Afternoon Trading	07/23/07	MT
Top Midday Gainers	07/23/07	MT
Tabula Rasa HealthCare Enters With Plan of Merger With Nautic Partners Affiliate; Shares Rise Pre-Bell	07/23/07	MT
Tabula Rasa HealthCare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/23/07	CI
Earnings Flash (TRHC) TABULA RASA HEALTHCARE Reports Q2 Revenue $90M, vs. Street Est of $88.9M	07/23/07	MT
Exact Care Pharmacy, LLC entered into a definitive agreement to acquire Tabula Rasa HealthCare, Inc. from Indaba Capital Fund, L.P, managed by Indaba Capital Management, L.P. and others for approximately $320 million.	07/23/07	CI
Tabula Rasa Healthcare, Inc. Appoints Michael Bruno as Chief Accounting Officer	05/23/05	CI
SVB Securities Upgrades Tabula Rasa HealthCare to Outperform From Market Perform, Adjusts Price Target to $10 From $7	10/23/10	MT
Transcript : Tabula Rasa HealthCare, Inc., Q1 2023 Earnings Call, May 09, 2023	09/23/09
Tabula Rasa HealthCare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/23/09	CI
Earnings Flash (TRHC) TABULA RASA HEALTHCARE Posts Q1 Revenue $88.3M	09/23/09	MT
Tabula Rasa Healthcare, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023 and Full Year Ending December 31, 2023	09/23/09	CI
North American Morning Briefing : Caution Dominates Ahead of Bank Earnings	14/23/14	DJ
Tabula Rasa HealthCare Raises Q1 Revenue Guidance; Names Brian Adams as President, CEO	14/23/14	MT
Tabula Rasa Healthcare, Inc. Provides Revenue Guidance for the First Quarter of 2023	14/23/14	CI
Tabula Rasa Healthcare, Inc. Appoints Brian Adams as Chief Executive Officer	14/23/14	CI
Tabula Rasa Healthcare, Inc. Announces Executive Changes	14/23/14	CI
Transcript : Tabula Rasa HealthCare, Inc., Q4 2022 Earnings Call, Mar 07, 2023	07/23/07

Chart Tabula Rasa HealthCare, Inc.

Duration

Period

More charts

Company Profile

Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.

Sector

Advanced Medical Equipment & Technology

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+5.91%	3.3TCr
PRO MEDICUS LIMITED	+19.40%	801.14Cr
EVOLENT HEALTH, INC.	-29.52%	266.96Cr
OMNICELL, INC.	-13.29%	149.85Cr
VERADIGM INC.	-28.02%	127.44Cr
LUNIT INC.	-30.53%	120.16Cr
SIMULATIONS PLUS, INC.	+11.35%	100Cr
B-SOFT CO.,LTD.	-38.17%	86Cr
SURGICAL SCIENCE SWEDEN AB	-23.12%	67Cr

Medical Software & Technology Services